Modipran 20 & 40 mg Dispersible tablets.
PDF Leaflet Revision Date: 23 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive disorders, obsessive-compulsive disorder, and bulimia nervosa.
Dosage (summary)
20 mg daily for depression; 60 mg daily for bulimia; 20-60 mg daily for OCD.
Special Populations
- Elderly patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established; potential risks in pregnancy and breastfeeding.
Key Drug Interactions
- MAOIs
- Tamoxifen
- Alcohol
- Linezolid
Contraindications
- Hypersensitivity to fluoxetine
- Severe renal impairment
- Children under 18
Common side effects
- Headache
- Nausea
- Insomnia
- Fatigue
- Diarrhoea
Counselling Points
- Take in the morning
- Avoid alcohol
- Monitor for mood changes
Serious warnings
- Serotonin syndrome
- Suicidal thoughts
- Withdrawal symptoms
Important Disclaimer
The Modipran 20 & 40 mg Dispersible tablets. professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
